Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2016.66.9929 on June 27 2016

Journal of Clinical Oncology, Vol 34, No 25 (September 1), 2016: pp. 2980-2987
© 2016 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gettinger, S.
Right arrow Articles by Hellmann, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gettinger, S.
Right arrow Articles by Hellmann, M. D.
Related Articles
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Delicious   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

  • Moving Programmed Death-1 Inhibitors to the Front Lines in Non–Small-Cell Lung Cancer
    Justin F. Gainor
    JCO 2016 34: 2953-2955 [Full Text]


This article has been cited by other articles:


Home page
Cancer DiscoveryHome page
J. J. Lin, G. J. Riely, and A. T. Shaw
Targeting ALK: Precision Medicine Takes on Drug Resistance
Cancer Discovery, February 1, 2017; 7(2): 137 - 155.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. A. Rizvi, M. D. Hellmann, J. R. Brahmer, R. A. Juergens, H. Borghaei, S. Gettinger, L. Q. Chow, D. E. Gerber, S. A. Laurie, J. W. Goldman, et al.
Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 1, 2016; 34(25): 2969 - 2979.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2016 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online